Notice: This company has been marked as potentially delisted and may not be actively trading. Deciphera Pharmaceuticals (DCPH) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Deciphera Pharmaceuticals Short Interest DataDeciphera Pharmaceuticals (DCPH) has a short interest of 3.17 million shares, representing 5.71% of the float (the number of shares available for trading by the public). This marks a -19.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 1.29 million shares to cover all short positions.Current Short Interest3,170,000 sharesPrevious Short Interest3,920,000 sharesChange Vs. Previous Month-19.13%Dollar Volume Sold Short$80.96 millionShort Interest Ratio1.7 Days to CoverLast Record DateMay 31, 2024Outstanding Shares86,476,000 sharesFloat Size55,520,000 sharesShort Percent of Float5.71%Today's Trading Volume600 sharesAverage Trading Volume1,292,551 sharesToday's Volume Vs. Average0% Short Selling Deciphera Pharmaceuticals? Sign up to receive the latest short interest report for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDCPH Short Interest Over TimeDCPH Days to Cover Over TimeDCPH Percentage of Float Shorted Over Time Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Deciphera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20243,170,000 shares $80.96 million -19.1%5.7%1.7 $25.54 5/15/20243,920,000 shares $99.76 million -33.0%7.3%2.3 $25.45 4/30/20245,850,000 shares $147.83 million +1.7%11.7%3.8 $25.27 4/15/20245,750,000 shares $85.68 million -5.1%11.5%10.9 $14.90 3/31/20246,060,000 shares $95.32 million +7.3%12.3%11.2 $15.73 3/15/20245,650,000 shares $88.08 million +2.5%11.4%10.6 $15.59 Get the Latest News and Ratings for DCPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/29/20245,510,000 shares $91.96 million No Change11.2%9.8 $16.69 2/15/20245,510,000 shares $87.72 million +3.2%11.2%10 $15.92 1/31/20245,340,000 shares $76.47 million +7.4%10.9%9.6 $14.32 1/15/20244,970,000 shares $73.75 million +1.2%10.2%7.5 $14.84 12/31/20234,910,000 shares $79.20 million +0.4%10.1%6.9 $16.13 12/15/20234,890,000 shares $78.00 million -15.0%10.1%6.8 $15.95 11/30/20235,750,000 shares $72.51 million +3.6%11.9%8.2 $12.61 11/15/20235,550,000 shares $68.49 million +41.9%11.5%8.6 $12.34 10/31/20233,910,000 shares $46.88 million -3.0%8.1%6 $11.99 10/15/20234,030,000 shares $44.13 million -0.3%8.5%7.9 $10.95 9/30/20234,040,000 shares $51.39 million -7.1%8.5%8.6 $12.72 9/15/20234,350,000 shares $58.38 million +2.4%9.1%10.6 $13.42 8/31/20234,250,000 shares $59.67 million +4.2%7.8%9.9 $14.04 8/15/20234,080,000 shares $63.16 million -1.0%7.5%9.1 $15.48 7/31/20234,120,000 shares $55.70 million +6.5%7.6%9.3 $13.52 7/15/20233,870,000 shares $54.22 million +2.1%7.1%7.8 $14.01 6/30/20233,790,000 shares $53.36 million -14.1%6.7%7.1 $14.08 6/15/20234,410,000 shares $64.12 million +2.3%8.1%7.9 $14.54 5/31/20234,310,000 shares $58.19 million +14.9%8.0%6.9 $13.50 5/15/20233,750,000 shares $53.33 million +11.0%7.0%5.8 $14.22 4/30/20233,380,000 shares $48.03 million +0.3%6.3%4.9 $14.21 4/15/20233,370,000 shares $49.00 million -40.9%6.5%4.5 $14.54 3/31/20235,700,000 shares $88.07 million +6.9%11.0%7.1 $15.45 3/15/20235,330,000 shares $89.22 million -0.7%10.3%6.3 $16.74 2/28/20235,370,000 shares $77.87 million No Change10.3%6.9 $14.50 2/15/20235,370,000 shares $83.13 million +7.6%10.4%7.1 $15.48 1/31/20234,990,000 shares $84.88 million +4.8%10.8%6.9 $17.01 1/15/20234,760,000 shares $102.34 million -33.7%10.0%7 $21.50 12/30/20227,180,000 shares $117.68 million -6.5%15.1%12.4 $16.39 12/15/20227,680,000 shares $120.58 million +7.7%16.1%13.9 $15.70 11/30/20227,130,000 shares $113.44 million -2.9%15.0%11 $15.91 11/15/20227,340,000 shares $115.53 million +2.4%15.5%10.4 $15.74 10/31/20227,170,000 shares $116.30 million -2.9%15.1%9.4 $16.22 10/15/20227,380,000 shares $123.47 million -1.9%15.7%9.1 $16.73Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 9/30/20227,520,000 shares $139.12 million +0.8%16.0%8.9 $18.50 9/15/20227,460,000 shares $147.86 million -5.1%15.9%8.4 $19.82 8/31/20227,860,000 shares $127.57 million +9.6%16.8%8.4 $16.23 8/15/20227,170,000 shares $119.31 million +1.7%15.3%7.6 $16.64 7/31/20227,050,000 shares $89.46 million +2.0%15.2%6.8 $12.69 7/15/20226,910,000 shares $89.90 million -3.6%14.9%5.9 $13.01 6/30/20227,170,000 shares $94.29 million -0.8%15.5%5.8 $13.15 6/15/20227,230,000 shares $84.01 million +7.8%15.6%6 $11.62 5/31/20226,710,000 shares $72.74 million -11.1%14.5%5.4 $10.84 5/15/20227,550,000 shares $77.84 million +11.4%16.3%5.8 $10.31 4/30/20226,780,000 shares $68.61 million -6.1%16.1%5 $10.12 4/15/20227,220,000 shares $75.45 million +10.7%18.0%5.7 $10.45 3/31/20226,520,000 shares $60.44 million -6.9%N/A5.1 $9.27 3/15/20227,000,000 shares $54.04 million -3.6%17.4%4.5 $7.72 2/28/20227,260,000 shares $55.97 million +10.5%18.1%4.3 $7.71 2/15/20226,570,000 shares $62.09 million +0.6%16.4%3.5 $9.45 1/31/20226,530,000 shares $55.05 million +4.5%17.5%3 $8.43 1/15/20226,250,000 shares $55.44 million +0.5%N/A2.5 $8.87 12/31/20216,220,000 shares $60.77 million +44.7%16.6%2.6 $9.77 12/15/20214,300,000 shares $39.69 million +51.9%11.5%2.1 $9.23 11/30/20212,830,000 shares $24.42 million +36.1%7.6%1.7 $8.63 11/15/20212,080,000 shares $19.22 million -15.5%5.6%1.5 $9.24 10/29/20212,460,000 shares $82.14 million +5.6%6.8%2.2 $33.39 10/15/20212,330,000 shares $81.15 million -10.0%6.5%6.4 $34.83 9/30/20212,590,000 shares $88.01 million +0.8%7.2%7.4 $33.98 9/15/20212,570,000 shares $79.77 million -7.6%7.1%7.5 $31.04 8/31/20212,780,000 shares $87.57 million -2.1%7.7%8.1 $31.50 8/13/20212,840,000 shares $80.37 million -2.4%7.5%7.9 $28.30 7/30/20212,910,000 shares $88.73 million -2.4%7.7%7.7 $30.49 7/15/20212,980,000 shares $100.58 million -4.8%7.6%7.5 $33.75 6/30/20213,130,000 shares $114.59 million -1.6%8.0%7.3 $36.61 6/15/20213,180,000 shares $114.10 million -2.8%8.1%7.5 $35.88 5/28/20213,270,000 shares $110.33 million -16.2%8.3%7.8 $33.74 5/14/20213,900,000 shares $127.65 million -8.2%N/A9 $32.73 4/30/20214,250,000 shares $198.82 million +6.5%N/A9.3 $46.78 4/15/20213,990,000 shares $183.38 million +5.0%N/A8.9 $45.96 3/31/20213,800,000 shares $157.81 million +10.5%N/A8.6 $41.53 3/15/20213,440,000 shares $148.33 million +4.6%N/A7.6 $43.12 2/26/20213,290,000 shares $140.12 million +21.4%N/A7.3 $42.59 2/12/20212,710,000 shares $134.77 million -15.3%N/A6.3 $49.73 1/29/20213,200,000 shares $142.85 million -11.4%N/A8.2 $44.64 1/15/20213,610,000 shares $184.72 million No ChangeN/A9.8 $51.17 12/31/20203,610,000 shares $210.07 million -3.5%N/A10.7 $58.19 12/15/20203,740,000 shares $213.11 million +3.6%N/A10.6 $56.98 11/30/20203,610,000 shares $225.08 million -5.0%N/A9.7 $62.35 11/15/20203,800,000 shares $247.34 million No Change10.0%10.6 $65.09 10/30/20203,800,000 shares $224.09 million -5.5%10.0%11.1 $58.97 10/15/20204,020,000 shares $225.28 million -3.8%10.7%11.1 $56.04 9/30/20204,180,000 shares $214.43 million +10.6%11.1%11.4 $51.30 9/15/20203,780,000 shares $194.63 million -5.3%10.0%9.2 $51.49Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 8/31/20203,990,000 shares $179.59 million -6.1%10.6%9.4 $45.01 8/14/20204,250,000 shares $192.40 million -0.9%11.3%9.7 $45.27 7/31/20204,290,000 shares $198.93 million -0.9%11.7%9.1 $46.37 7/15/20204,330,000 shares $227.15 million -1.6%11.9%8.5 $52.46 6/30/20204,400,000 shares $257.53 million +25.0%12.1%8.3 $58.53 6/15/20203,520,000 shares $206.41 million +12.1%9.7%6.8 $58.64 5/29/20203,140,000 shares $183.91 million +11.0%8.6%5.4 $58.57 5/15/20202,830,000 shares $137.17 million -5.0%7.8%4.7 $48.47 4/30/20202,980,000 shares $172.78 million +2.1%8.2%4.6 $57.98 4/15/20202,920,000 shares $127.37 million -4.6%8.1%4.9 $43.62 3/31/20203,060,000 shares $146.94 million +17.2%8.4%4.9 $48.02 3/13/20202,610,800 shares $113.10 million -8.1%7.5%3.8 $43.32 2/28/20202,840,000 shares $103.69 million -4.7%8.1%4.8 $36.51 2/14/20202,980,000 shares $148.97 million +16.4%8.9%5.3 $49.99 1/31/20202,560,000 shares $139.34 million -3.0%8.2%4.8 $54.43 1/15/20202,640,000 shares $181.74 million +5.6%8.5%4.5 $68.84 12/31/20192,500,000 shares $165.63 million +7.8%8.0%4.5 $66.25 DCPH Short Interest - Frequently Asked Questions What is Deciphera Pharmaceuticals' current short interest? Short interest is the volume of Deciphera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 3,170,000 shares of DCPH short. 5.71% of Deciphera Pharmaceuticals' shares are currently sold short. Learn More on Deciphera Pharmaceuticals' current short interest. What is a good short interest ratio for Deciphera Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DCPH shares currently have a short interest ratio of 2.0. Learn More on Deciphera Pharmaceuticals's short interest ratio. What is a good short interest percentage for Deciphera Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.71% of Deciphera Pharmaceuticals' floating shares are currently sold short. Is Deciphera Pharmaceuticals' short interest increasing or decreasing? Deciphera Pharmaceuticals saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 3,170,000 shares, a drop of 19.1% from the previous total of 3,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Deciphera Pharmaceuticals' float size? Deciphera Pharmaceuticals currently has issued a total of 86,476,000 shares. Some of Deciphera Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Deciphera Pharmaceuticals currently has a public float of 55,520,000 shares. How does Deciphera Pharmaceuticals' short interest compare to its competitors? 5.71% of Deciphera Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Deciphera Pharmaceuticals: Agios Pharmaceuticals, Inc. (7.45%), Syndax Pharmaceuticals, Inc. (12.35%), Xencor, Inc. (6.84%), Seres Therapeutics, Inc. (10.61%), Roivant Sciences Ltd. (13.34%), Revolution Medicines, Inc. (9.97%), Legend Biotech Co. (6.56%), Intra-Cellular Therapies, Inc. (2.29%), Viking Therapeutics, Inc. (12.91%), Lantheus Holdings, Inc. (6.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Deciphera Pharmaceuticals stock? Short selling DCPH is an investing strategy that aims to generate trading profit from Deciphera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Deciphera Pharmaceuticals? A short squeeze for Deciphera Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DCPH, which in turn drives the price of the stock up even further. How often is Deciphera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DCPH, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies Agios Pharmaceuticals Short Interest Data Syndax Pharmaceuticals Short Interest Data Xencor Short Interest Data Seres Therapeutics Short Interest Data Roivant Sciences Short Interest Data Revolution Medicines Short Interest Data Legend Biotech Short Interest Data Intra-Cellular Therapies Short Interest Data Viking Therapeutics Short Interest Data Lantheus Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DCPH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Deciphera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCPH Stock Alerts